• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液系统癌症研究:荷兰患者的优先事项是什么?

Research in haematological cancers: What do patients in the Netherlands prioritise?

作者信息

Schölvinck Anne-Floor M, de Graaff Bert M B, van den Beld Mechteld J, Broerse Jacqueline E W

机构信息

UMC Utrecht, Utrecht, The Netherlands.

Department of Health Care Governance, Institute of Health Policy and Management (iBMG), Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12989. doi: 10.1111/ecc.12989. Epub 2019 Jan 23.

DOI:10.1111/ecc.12989
PMID:30675743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9285610/
Abstract

INTRODUCTION

The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation.

METHODS

A mixed-method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands.

RESULTS

Patients' physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients' quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients' everyday problems are not all directly reflected in the research agenda.

CONCLUSIONS

Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives.

摘要

引言

患者的经验性知识可为研究团体提供关于疾病的补充观点。本研究的目的是确定血液癌症患者及接受过干细胞移植的人群的日常问题和研究需求,并确定其优先顺序。

方法

采用了一种混合方法参与式研究方法(对话模型),包括访谈(n = 19)、四次焦点小组讨论(n = 27)、一份问卷(n = 146)以及与荷兰患者举行的一次利益相关者对话会议(n = 30)。

结果

突出了患者的身体不适、心理社会问题、医疗保健系统问题和政策问题。受访者将旨在研究潜在影响生存的因素(如生活方式)的研究以及旨在改善患者生活质量(如改善记忆和注意力问题)的研究列为优先事项。主题还集中在身体不适、因果机制以及医疗保健组织和政策方面。具有社会科学性质的研究代表性不足,因此患者的日常问题并未全部直接反映在研究议程中。

结论

我们的研究结果表明,患者除了强调提高生存率的重要性外,还明确希望增强对自己生活的掌控。

相似文献

1
Research in haematological cancers: What do patients in the Netherlands prioritise?血液系统癌症研究:荷兰患者的优先事项是什么?
Eur J Cancer Care (Engl). 2019 Mar;28(2):e12989. doi: 10.1111/ecc.12989. Epub 2019 Jan 23.
2
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
3
Italian onco-haematological patients' preferences in bad news communication: a preliminary investigation.意大利肿瘤血液病患者对不良消息沟通的偏好:初步调查。
BMC Cancer. 2021 May 17;21(1):555. doi: 10.1186/s12885-021-08181-0.
4
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences.血液系统恶性肿瘤患者对信息的感知需求:与信息满意度及治疗决策偏好的关联
Hematol Oncol. 2015 Jun;33(2):85-98. doi: 10.1002/hon.2138. Epub 2014 May 9.
5
Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study.异基因造血干细胞移植(HSCT)治疗血液恶性肿瘤后对癌症复发的恐惧:一项横断面研究。
Eur J Oncol Nurs. 2020 Dec;49:101845. doi: 10.1016/j.ejon.2020.101845. Epub 2020 Oct 10.
6
Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.姑息治疗专家对转介血液科患者至其服务的看法:一项定性研究的结果。
BMC Palliat Care. 2018 Feb 21;17(1):33. doi: 10.1186/s12904-018-0289-1.
7
Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors.血液癌症患者对癌症复发的恐惧:探索社会人口统计学、心理、存在主义和疾病相关因素。
Support Care Cancer. 2020 Dec;28(12):5973-5982. doi: 10.1007/s00520-020-05434-9. Epub 2020 Apr 13.
8
Establishing the research agenda for oral healthcare using the Dialogue Model-patient involvement in a joint research agenda with practitioners.利用对话模式为口腔保健制定研究议程——患者与从业者共同参与制定研究议程。
Eur J Oral Sci. 2022 Feb;130(1):e12842. doi: 10.1111/eos.12842. Epub 2021 Dec 22.
9
Argentina. Telling the truth to cancer patients in a multicultural society.
Ann N Y Acad Sci. 1997 Feb 20;809:152-62. doi: 10.1111/j.1749-6632.1997.tb48078.x.
10
Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies.与血液系统恶性肿瘤患者指定医疗代理人及撰写预立医疗指示相关的因素。
BMC Palliat Care. 2014 Dec 11;13:57. doi: 10.1186/1472-684X-13-57. eCollection 2014.

引用本文的文献

1
Changes in physical fitness in acute leukemia patients during chemotherapy.急性白血病患者化疗期间体能的变化
Sci Rep. 2025 Feb 15;15(1):5632. doi: 10.1038/s41598-025-89703-9.
2
Ethical considerations for engaging frail and seriously ill patients as partners in research: sub-analysis of a systematic review.将体弱和重症患者纳入研究伙伴的伦理考量:一项系统评价的子分析
Res Involv Engagem. 2021 Jan 31;7(1):8. doi: 10.1186/s40900-021-00254-5.
3
Partnering with frail or seriously ill patients in research: a systematic review.在研究中与体弱或重病患者合作:一项系统综述。

本文引用的文献

1
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
2
Describing patients' needs in the context of research priorities in patients with multiple myeloma or Waldenstrom's disease: A truly patient-driven study.在多发性骨髓瘤或华氏巨球蛋白血症患者的研究重点背景下描述患者需求:一项真正由患者驱动的研究。
Z Evid Fortbild Qual Gesundhwes. 2016;112:11-8. doi: 10.1016/j.zefq.2016.01.005.
3
The first step in ensuring patient-centred quality of care: ask the patient.
Res Involv Engagem. 2020 Sep 11;6:52. doi: 10.1186/s40900-020-00225-2. eCollection 2020.
确保以患者为中心的医疗质量的第一步:询问患者。
Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12435. Epub 2016 Jan 10.
4
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
5
Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.异基因造血干细胞移植后健康相关生活质量的频繁和长期随访。
Eur J Cancer Care (Engl). 2015 Nov;24(6):898-910. doi: 10.1111/ecc.12350. Epub 2015 Jul 7.
6
Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes.是时候在慢性髓性白血病患者的靶向治疗评估中开启新纪元了:纳入生活质量和其他患者报告的结局。
Crit Rev Oncol Hematol. 2012 Feb;81(2):123-35. doi: 10.1016/j.critrevonc.2011.02.007. Epub 2011 Mar 24.
7
The pharmaceuticalisation of society? A framework for analysis.社会的药物化?一个分析框架。
Sociol Health Illn. 2011 Jul;33(5):710-25. doi: 10.1111/j.1467-9566.2011.01320.x. Epub 2011 Mar 4.
8
Developing voice and empowerment: the first step towards a broad consultation in research agenda setting.发展声音和赋权:广泛参与研究议程制定的第一步。
J Intellect Disabil Res. 2011 Apr;55(4):411-21. doi: 10.1111/j.1365-2788.2011.01388.x. Epub 2011 Feb 15.
9
Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives.患者-专家研究伙伴关系:如何激发患者观点的包容性。
Health Expect. 2011 Sep;14(3):225-39. doi: 10.1111/j.1369-7625.2010.00647.x. Epub 2010 Dec 22.
10
Determining research priorities for young people with haematological cancer: a value-weighting approach.确定血液系统癌症青年患者的研究重点:一种价值加权方法。
Eur J Cancer. 2010 Dec;46(18):3263-70. doi: 10.1016/j.ejca.2010.06.013. Epub 2010 Jul 13.